• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺素给药时机可预测去甲肾上腺素难治性感染性休克对肾上腺素的反应性:一项回顾性研究

Timing of administration of epinephrine predicts the responsiveness to epinephrine in norepinephrine-refractory septic shock: a retrospective study.

作者信息

Kasugai Daisuke, Nishikimi Mitsuaki, Nishida Kazuki, Higashi Michiko, Yamamoto Takanori, Numaguchi Atsushi, Takahashi Kunihiko, Matsui Shigeyuki, Matsuda Naoyuki

机构信息

Department of Emergency and Critical Care, Nagoya, University Graduate School of Medicine, Tsurumai-cho 64, Syowa-ku, Nagoya, Aichi 4668560 Japan.

2Department of Biostatistics, Nagoya University Graduate School of Medicine, Tsurumai-cho 64, Syowa-ku, Nagoya, Aichi 4668560 Japan.

出版信息

J Intensive Care. 2019 Apr 5;7:20. doi: 10.1186/s40560-019-0377-1. eCollection 2019.

DOI:10.1186/s40560-019-0377-1
PMID:30992991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6451296/
Abstract

BACKGROUND

Currently, the appropriate method of management of patients with refractory septic shock remains unclear. This study aimed to evaluate the factors associated with response to epinephrine in norepinephrine-refractory septic shock.

METHODS

A retrospective single-center observational study was performed using data from adult patients (≥ 18 years old) admitted to our emergency and medical intensive care unit (ICU) from January 2014 to December 2017 who had received epinephrine to treat norepinephrine-refractory septic shock. The response was considered positive if there was increase in mean arterial pressure of 10 mmHg or decrease in arterial lactate level 3 h after epinephrine administration.

RESULTS

Forty-one patients were included: 24 responders (59%) and 17 non-responders (41%). Responders showed higher rate of survival from shock (92% vs. 18%;  < 0.001), and 28-day survival (83% vs. 18%;  < 0.001). In multivariable analysis, time of epinephrine administration after ICU admission (odds ratio [OR] 0.48; 95% confidence interval [CI] 0.27-0.87;  = 0.011) and SOFA score (OR 0.19; 95% CI 0.04-0.88;  = 0.034) were associated with epinephrine response. Time of epinephrine administration was also significantly associated with survival from shock (OR 0.42;  = 0.005) and 28-day survival (OR 0.14;  = 0.006), while SOFA score did not. Using inverse probability of treatment weighing (IPTW) adjustment of propensity score, epinephrine administration later than 24 h after ICU admission was associated with poor response (OR 0.07; 95% CI 0.02-0.21;  < 0.001).

CONCLUSIONS

Early administration of epinephrine after ICU admission (i.e., within 24 h) is associated with better hemodynamic status in patients with refractory septic shock.

摘要

背景

目前,难治性感染性休克患者的恰当管理方法仍不明确。本研究旨在评估去甲肾上腺素难治性感染性休克患者对肾上腺素反应的相关因素。

方法

进行一项回顾性单中心观察性研究,使用2014年1月至2017年12月入住我们急诊和医学重症监护病房(ICU)的成年患者(≥18岁)的数据,这些患者接受了肾上腺素治疗去甲肾上腺素难治性感染性休克。如果肾上腺素给药后3小时平均动脉压升高10 mmHg或动脉乳酸水平降低,则反应被认为是阳性的。

结果

纳入41例患者:24例反应者(59%)和17例无反应者(41%)。反应者的休克生存率(92%对18%;P<0.001)和28天生存率(83%对18%;P<0.001)更高。在多变量分析中,入住ICU后肾上腺素给药时间(比值比[OR]0.48;95%置信区间[CI]0.27 - 0.87;P = 0.011)和序贯器官衰竭评估(SOFA)评分(OR 0.19;95%CI 0.04 - 0.88;P = 0.034)与肾上腺素反应相关。肾上腺素给药时间也与休克生存率(OR 0.42;P = 0.005)和28天生存率(OR 0.14;P = 0.006)显著相关,而SOFA评分则不然。使用倾向评分的逆概率处理加权(IPTW)调整后,入住ICU后24小时后给予肾上腺素与反应不佳相关(OR 0.07;95%CI 0.02 - 0.21;P<0.001)。

结论

入住ICU后早期(即24小时内)给予肾上腺素与难治性感染性休克患者更好的血流动力学状态相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be76/6451296/6c1ddc4d79c2/40560_2019_377_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be76/6451296/6c1ddc4d79c2/40560_2019_377_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be76/6451296/6c1ddc4d79c2/40560_2019_377_Fig1_HTML.jpg

相似文献

1
Timing of administration of epinephrine predicts the responsiveness to epinephrine in norepinephrine-refractory septic shock: a retrospective study.肾上腺素给药时机可预测去甲肾上腺素难治性感染性休克对肾上腺素的反应性:一项回顾性研究
J Intensive Care. 2019 Apr 5;7:20. doi: 10.1186/s40560-019-0377-1. eCollection 2019.
2
Maximum Norepinephrine Dosage Within 24 Hours as an Indicator of Refractory Septic Shock: A Retrospective Study.24 小时内最大去甲肾上腺素剂量作为难治性感染性休克的指标:一项回顾性研究。
J Intensive Care Med. 2020 Nov;35(11):1285-1289. doi: 10.1177/0885066619860736. Epub 2019 Jun 27.
3
[Lactic acid, lactate clearance and procalcitonin in assessing the severity and predicting prognosis in sepsis].[乳酸、乳酸清除率及降钙素原在评估脓毒症严重程度及预测预后中的作用]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):449-453. doi: 10.3760/cma.j.cn121430-20200129-00086.
4
[Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].[血清乳酸、降钙素原及严重程度评分对脓毒症休克患者短期预后的联合预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):281-285. doi: 10.3760/cma.j.cn121430-20201113-00715.
5
Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.去甲肾上腺素和血管加压素与去甲肾上腺素和肾上腺素治疗脓毒性休克成人患者的比较。
Ann Pharmacother. 2019 Sep;53(9):877-885. doi: 10.1177/1060028019843664. Epub 2019 Apr 8.
6
Predictors of response to fixed-dose vasopressin in adult patients with septic shock.成年感染性休克患者对固定剂量血管加压素反应的预测因素。
Ann Intensive Care. 2018 Mar 6;8(1):35. doi: 10.1186/s13613-018-0379-5.
7
[Value of pulse indicator continuous cardiac output monitoring of cardiac function in septic shock patients: a prospective study].[脉搏指示连续心输出量监测在脓毒症休克患者心功能评估中的价值:一项前瞻性研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jan;27(1):22-7. doi: 10.3760/cma.j.issn.2095-4352.2015.01.006.
8
Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.去甲肾上腺素和多巴酚丁胺与肾上腺素用于感染性休克血流动力学、乳酸代谢及胃张力测定变量的比较:一项前瞻性随机研究。
Intensive Care Med. 1997 Mar;23(3):282-7. doi: 10.1007/s001340050329.
9
[Intestinal barrier dysfunction and its related factors in patients with sepsis].[脓毒症患者的肠道屏障功能障碍及其相关因素]
Zhonghua Yi Xue Za Zhi. 2016 Nov 29;96(44):3568-3572. doi: 10.3760/cma.j.issn.0376-2491.2016.44.007.
10
[Prognostic value of arterial lactate combined with central venous-to-arterial carbon dioxide difference to arterial-to-central venous oxygen content difference ratio in septic shock patients].动脉血乳酸联合中心静脉与动脉血二氧化碳分压差与动脉血与中心静脉血氧含量差比值对脓毒症休克患者的预后价值
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jan;32(1):39-43. doi: 10.3760/cma.j.cn121430-20191226-00007.

引用本文的文献

1
Altered neutrophil-to-lymphocyte ratio in sepsis secondary to canine parvoviral enteritis treated with and without an immunomodulator in puppies.幼犬感染犬细小病毒肠炎继发脓毒症时,使用和未使用免疫调节剂治疗的中性粒细胞与淋巴细胞比值变化情况
Front Vet Sci. 2022 Nov 8;9:995443. doi: 10.3389/fvets.2022.995443. eCollection 2022.
2
The Development of a Protocol for Critical Illness-Related Corticosteroid Insufficiency (CIRCI) at a Tertiary Hospital.三级医院危重病相关皮质激素不足(CIRCI)处理方案的制定。
J ASEAN Fed Endocr Soc. 2022;37(1):14-23. doi: 10.15605/jafes.037.01.03. Epub 2022 Feb 26.
3
Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation.

本文引用的文献

1
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).《2016年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2016)
J Intensive Care. 2018 Feb 2;6:7. doi: 10.1186/s40560-017-0270-8. eCollection 2018.
2
Angiotensin II for the Treatment of Vasodilatory Shock.血管扩张性休克的血管紧张素 II 治疗。
N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21.
3
Outcome of patients with septic shock and high-dose vasopressor therapy.感染性休克患者及高剂量血管活性药物治疗的结果
CXCR4 和 CXCR7 抑制在急性腹膜炎中具有保护作用。
Front Immunol. 2020 Mar 10;11:407. doi: 10.3389/fimmu.2020.00407. eCollection 2020.
4
Organ Dysfunction in Sepsis: An Ominous Trajectory From Infection To Death.脓毒症器官功能障碍:从感染到死亡的凶险病程。
Yale J Biol Med. 2019 Dec 20;92(4):629-640. eCollection 2019 Dec.
Ann Intensive Care. 2017 Dec;7(1):43. doi: 10.1186/s13613-017-0261-x. Epub 2017 Apr 20.
4
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症和脓毒性休克管理国际指南:2016 年版。
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.
5
Reasons for death in patients with sepsis and septic shock.脓毒症和脓毒性休克患者的死亡原因。
J Crit Care. 2017 Apr;38:284-288. doi: 10.1016/j.jcrc.2016.11.036. Epub 2016 Dec 2.
6
Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.在生存分析中使用治疗权重逆概率(IPTW)时的方差估计。
Stat Med. 2016 Dec 30;35(30):5642-5655. doi: 10.1002/sim.7084. Epub 2016 Aug 22.
7
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
8
Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.血管升压药治疗感染性休克:系统评价与Meta分析
PLoS One. 2015 Aug 3;10(8):e0129305. doi: 10.1371/journal.pone.0129305. eCollection 2015.
9
Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.采用多模式血管功能衰竭方法对去甲肾上腺素依赖性和难治性感染性休克进行早期预测。
J Crit Care. 2015 Aug;30(4):739-43. doi: 10.1016/j.jcrc.2015.03.029. Epub 2015 Apr 8.
10
Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock.严重细菌性脓毒症休克时难治性心血管功能障碍的静脉动脉体外膜氧合支持。
Crit Care Med. 2013 Jul;41(7):1616-26. doi: 10.1097/CCM.0b013e31828a2370.